Livsmed Statistics

Total Valuation

Livsmed has a market cap or net worth of KRW 1.14 trillion. The enterprise value is 1.14 trillion.

Market Cap	1.14T
Enterprise Value	1.14T

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Livsmed has 24.68 million shares outstanding. The number of shares has increased by 47.30% in one year.

Current Share Class	24.68M
Shares Outstanding	24.68M
Shares Change (YoY)	+47.30%
Shares Change (QoQ)	-0.14%
Owned by Insiders (%)	39.47%
Owned by Institutions (%)	n/a
Float	13.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	25.85
PB Ratio	21.30
P/TBV Ratio	21.85
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-56.17
EV / Sales	25.84
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-28.09

Financial Position

The company has a current ratio of 3.52, with a Debt / Equity ratio of 0.23.

Current Ratio	3.52
Quick Ratio	2.63
Debt / Equity	0.23
Debt / EBITDA	n/a
Debt / FCF	-0.30
Interest Coverage	-2.66

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-38.33%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	3,326,790

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Livsmed had revenue of KRW 44.16 billion and -20.32 billion in losses. Loss per share was -973.43.

Revenue	44.16B
Gross Profit	26.10B
Operating Income	-22.89B
Pretax Income	-20.32B
Net Income	-20.32B
EBITDA	-20.52B
EBIT	-22.89B
Loss Per Share	-973.43

Full Income Statement

Balance Sheet

The company has 12.70 billion in cash and 12.26 billion in debt, giving a net cash position of 442.32 million or 17.92 per share.

Cash & Cash Equivalents	12.70B
Total Debt	12.26B
Net Cash	442.32M
Net Cash Per Share	17.92
Equity (Book Value)	53.59B
Book Value Per Share	2,417.15
Working Capital	36.79B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -33.75 billion and capital expenditures -6.87 billion, giving a free cash flow of -40.62 billion.

Operating Cash Flow	-33.75B
Capital Expenditures	-6.87B
Free Cash Flow	-40.62B
FCF Per Share	-1,645.83

Full Cash Flow Statement

Margins

Gross margin is 59.10%, with operating and profit margins of -51.85% and -46.01%.

Gross Margin	59.10%
Operating Margin	-51.85%
Pretax Margin	-46.01%
Profit Margin	-46.01%
EBITDA Margin	-46.46%
EBIT Margin	-51.85%
FCF Margin	n/a

Dividends & Yields

Livsmed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-47.30%
Shareholder Yield	-47.30%
Earnings Yield	-1.78%
FCF Yield	-3.56%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Livsmed has an Altman Z-Score of -5.29 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.29
Piotroski F-Score	2